Platelet aggregation: effects of cardiopulmonary bypass.
This study was designed to determine whether reduction in platelet aggregate microembolization during the first 30 minutes of cardiopulmonary bypass is due to thrombocytopenia or to decreased ability of platelets to aggregate. The total volume of platelet aggregates induced in blood by adenosine diphosphate (ADP) was measured with a Coulter counter. The volume of platelets in blood was calculated by multiplying hemocytometry platelet counts by the mean platelet volume. Immediately before cardiopulmonary bypass, the total volume of aggregates induced in blood by ADP (2muM) was reduced when compared to normal donors because of (1) a slight fall in the volume of platelets, and (2) reduction in the percentage by volume of platelets which aggregated. After 30 minutes on bypass, the volume of both platelets and aggregates fell, but a greater percentage of platelets aggregated. This indicates that reduction of platelet aggregate formation during cardiopulmonary bypass is due to thrombocytopenia. It also suggests that anesthesia, surgical trauma and heparinization alter platelet reactivity more than cardiopulmonary bypass.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000758:Anesthesia / Q000009:adverse effects; D001772:Blood Cell Count; D001792:Blood Platelets; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D006801:Humans; D010316:Particle Size; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation / Q000187:drug effects; D013921:Thrombocytopenia / Q000209:etiology; D013997:Time Factors
D000244:Adenosine Diphosphate